Check whether you have Fucidin or Fucidin H
The side-effect profile of a topical cream depends entirely on its active ingredients. Before interpreting risks, you must confirm whether your product is plain Fucidin or Fucidin H. The brand name alone does not indicate which version you have; the suffix “H” denotes the presence of an additional active ingredient that changes both the clinical purpose and the safety considerations.
UK Fucidin 20 mg/g cream contains only fusidic acid 20 mg/g. It is a topical antibiotic used to treat bacterial skin infections such as impetigo and infected eczema. It does not contain corticosteroids.
Fucidin H cream, by contrast, combines fusidic acid with hydrocortisone acetate. Hydrocortisone is classified as a mild corticosteroid. This combination is specifically indicated for eczema or dermatitis that has become secondarily infected with bacteria sensitive to fusidic acid.
Because Fucidin H contains a steroid, it carries risks not present in the plain antibiotic version. Always check the tube, carton, or patient information leaflet to verify exactly which product you are using. Do not assume the cream is safe or unsafe based solely on the primary brand name.
Side effects of plain Fucidin cream
Plain Fucidin is generally well tolerated by most users. In pooled clinical study data involving more than 4,700 recipients, the overall frequency of undesirable effects was reported as 2.3%. Most adverse reactions are localised to the skin where the cream is applied.
The most common issues fall into the “uncommon” category, affecting less than 1 in 100 people. These include itching (pruritus), rash, redness (erythema), and irritation at the application site. Some users may also experience mild pain or a burning sensation where the cream has been applied. In very rare cases, defined as affecting fewer than 1 in 1,000 people, allergic reactions such as hypersensitivity, angioedema (swelling beneath the skin), urticaria (hives), blistering, or conjunctivitis can occur.
The safety data for Fucidin cream applies specifically to the topical formulation. Side effects associated with oral fusidic acid tablets or fusidic-acid eye drops are not relevant to this cream. For instance, blurred vision or systemic gastrointestinal issues linked to other formulations do not typically arise from applying the plain antibiotic cream to intact or broken skin.
Extended or recurrent use of plain Fucidin may increase the risk of contact sensitisation and contribute to antibiotic resistance, but it does not carry the structural skin risks associated with steroids.
Fucidin H side effects and steroid-related risks
Fucidin H carries the same potential local reactions as plain Fucidin, but the addition of hydrocortisone introduces a different category of risks related to corticosteroid use. While itching, burning, and irritation remain common application-site reactions, the steroid component raises concerns about long-term skin changes.
Skin atrophy (thinning), striae (stretch marks), telangiectasia (visible blood vessels), rosacea-like symptoms, depigmentation, and increased hair growth are recognised class effects of topical corticosteroids. These issues are particularly associated with prolonged use or application to thin-skinned areas. Bruising may also occur during extended therapy.
Blurred vision is listed on the Fucidin H label as an effect with unknown frequency because available data cannot estimate how often it happens. This visual disturbance is not inherently an allergic reaction, but it warrants medical assessment. Topical corticosteroids can, in rare cases, lead to raised intraocular pressure or glaucoma, especially if used near the eyes or for prolonged periods. This risk is higher in individuals predisposed to these conditions.
Children may be more susceptible to systemic effects from topical corticosteroids than adults, including adrenal suppression and Cushing's syndrome, due to their larger surface-area-to-body-weight ratio and developing physiology. Steroid-containing creams require careful monitoring in paediatric patients.
Understanding Fucidin vs Fucidin H
Irritation, allergy, or a worsening skin condition?
Distinguishing between a normal local reaction, an allergic response, and the underlying condition worsening can be challenging. Mild itching or redness at the site of application is often temporary and may resolve as the skin adjusts to treatment. Persistent spreading redness, intense swelling, or blistering suggests a potential allergy or contact dermatitis.
Both Fucidin and Fucidin H contain excipients that can cause local skin reactions. For example, butylhydroxyanisole, cetyl alcohol, and potassium sorbate may trigger contact dermatitis, while polysorbate 60 has been associated with allergic reactions in some individuals. Not every adverse reaction is caused by the active medicinal ingredients; it may be a sensitivity to the cream's base formulation.
Aggravation of eczema or worsening of the skin infection is also possible, particularly if the bacterial strain is resistant to fusidic acid or if the inflammatory component of the condition is not adequately controlled. Irritation alone does not automatically prove an allergy, nor does redness confirm treatment failure. If symptoms spread beyond the original application site, become severe, or fail to improve after a few days of use, professional assessment is necessary to determine the cause and adjust the treatment plan accordingly.
Symptoms that need medical or emergency help
Some side effects require immediate emergency intervention, while others warrant prompt but non-emergency medical advice. Recognising the difference is critical for safety.
Anaphylaxis is a rare but life-threatening allergic reaction. Symptoms requiring immediate emergency help include sudden swelling of the lips, mouth, throat, or tongue; rapid or difficult breathing; throat tightness; difficulty swallowing; collapse; or marked confusion and unresponsiveness. In the UK, this requires calling 999 immediately. Do not drive yourself to hospital if you are experiencing these signs.
For Fucidin H users, blurred vision or other visual disturbances warrant prompt medical assessment. While not an emergency in itself unless accompanied by severe pain or sudden total vision loss, it indicates a potential ocular complication such as raised intraocular pressure that needs evaluation by an eye specialist.
Persistent or troublesome local irritation, worsening of the skin condition despite treatment, or signs of secondary infection (such as increased warmth, pus, or fever) should be discussed with a pharmacist or prescriber. These issues may indicate that the current treatment is unsuitable and requires modification.
Factors that can increase side-effect risks
The likelihood and severity of side effects depend heavily on how the product is used. Several factors significantly increase risk:
Extended or recurrent exposure increases the chance of both antibiotic resistance (with plain Fucidin) and steroid-related skin damage (with Fucidin H). Prolonged use of corticosteroids also raises the risk of systemic absorption, particularly in children or when large body surface areas are treated.
Application near the eyes is a high-risk behaviour for both creams. Butylhydroxyanisole in the formulation can irritate the eyes and mucous membranes. Using Fucidin H on the face or around the eyes increases the risk of skin thinning, rosacea, and visual disturbances like glaucoma. Prolonged use on the face should be avoided with Fucidin H.
Children are more vulnerable to systemic steroid effects due to their developing physiology. Contaminated clothing, bedding, or dressings that have come into contact with the cream can become highly flammable. Both labels warn users not to smoke or approach naked flames while treated, as washing may not completely remove product build-up from fabrics.
What to do when a side effect occurs
If you experience severe symptoms of anaphylaxis-such as difficulty breathing, throat swelling, or collapse-seek emergency medical help immediately by calling 999 in the UK. Do not attempt to manage these reactions at home.
For visual disturbances like blurred vision while using Fucidin H, stop applying the cream near the eyes and seek prompt medical advice to assess for potential ocular complications. If the skin condition worsens significantly, spreads rapidly, or shows signs of severe allergic reaction (such as widespread hives or blistering), contact a healthcare professional without delay.
For persistent, mild-to-moderate local irritation that does not resolve after a few days, consult a pharmacist or prescriber. They can determine whether the reaction is due to the active ingredient, an excipient, or an inappropriate diagnosis, and advise on alternative treatments if necessary.
Adhere strictly to prescribed duration limits. In the UK, a single course of Fucidin H should not normally exceed two weeks. A steroid-antibiotic combination like Fucidin H should not continue for more than seven days without clinical improvement. If symptoms persist beyond this window, do not independently restart or extend treatment, as this may mask underlying issues or increase resistance and steroid-related risks. Always follow the specific directions provided on your product's label or by your prescriber.
The side effects depend on whether you have plain Fucidin or Fucidin H, so check the tube, carton or leaflet because the brand name alone does not show which product you have. Plain Fucidin contains only fusidic acid, a topical antibiotic for bacterial skin infections such as impetigo and infected eczema. Fucidin H combines fusidic acid with hydrocortisone acetate, a mild corticosteroid, and is for eczema or dermatitis that has become secondarily infected with bacteria sensitive to fusidic acid. Plain Fucidin is generally well tolerated, with mostly local, uncommon reactions such as itching, rash, redness, irritation, and mild pain or burning; very rare allergic reactions include hypersensitivity, angioedema, urticaria, blistering, and conjunctivitis. Extended or recurrent use may increase the risk of contact sensitisation and contribute to antibiotic resistance, but it does not carry steroid-related structural skin risks. Safety data for the cream apply to the topical formulation; side effects of oral fusidic acid or eye drops are not relevant.
Fucidin H can cause the same local reactions but adds corticosteroid risks, particularly with prolonged use or application to thin-skinned areas: skin thinning, stretch marks, visible blood vessels, rosacea-like symptoms, depigmentation, increased hair growth, and possible bruising with extended therapy. Blurred vision is listed with unknown frequency and warrants medical assessment, and topical corticosteroids can rarely raise intraocular pressure or cause glaucoma, especially near the eyes or with prolonged use. Children may be more susceptible to systemic steroid effects such as adrenal suppression and Cushing's syndrome. Applying either cream near the eyes is high-risk, and Fucidin H on the face or around the eyes increases the risk of skin thinning, rosacea, and visual disturbances; prolonged use on the face should be avoided with Fucidin H. Some reactions may be due to excipients rather than the active ingredients, and worsening skin may reflect allergy, resistance, or inadequate control of the underlying condition; persistent spreading redness, intense swelling, blistering, or failure to improve after a few days requires professional assessment.
Seek emergency help immediately, by calling 999 in the UK, for signs of anaphylaxis such as sudden swelling of the lips, mouth, throat, or tongue; rapid or difficult breathing; throat tightness; difficulty swallowing; collapse; or marked confusion and unresponsiveness, and do not drive yourself. For Fucidin H, blurred vision or other visual disturbance needs prompt medical assessment unless it is accompanied by severe pain or sudden total vision loss, which makes it an emergency. Follow prescribed duration limits: in the UK a single course of Fucidin H should not normally exceed two weeks, and it should not continue for more than seven days without clinical improvement; do not independently restart or extend treatment. Both labels also warn that clothing, bedding, or dressings contaminated with the cream can be highly flammable, so do not smoke or approach naked flames while treated.
Source organization: electronic Medicines Compendium
Source organization: electronic Medicines Compendium
Source organization: NHS
Questions & comments
Please do not include passwords, medical record numbers, insurance information, financial information, precise addresses, or other confidential or directly identifying information in your message.